- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
The New York Post reported yesterday on four U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG) audits of state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism programs. Two of the programs whose audits were reported are contiguous to Michigan: Indiana and Wisconsin. No indication if or when the MDHHS ABA program will be audited by the Feds. Michigan-based Centria Healthcare LLC has distributed over half a billion in Medicaid reimbursements:
https://oig.hhs.gov/reports/work-plan/browse-work-plan-projects/srs-a-25-029/
HHS finds up to $600m ‘improper’ payments for autism services, errors on every bill checked in four states
By Chadwick Moore - March 3, 2026It’s not just Minnesota where people have bilked Medicaid for millions.
Federal auditors found $198 million “improper payments” for Medicaid-funded autism services in four states, and another $410 million may have been incorrectly billed.
The Department of Health and Human Services (HHS) put Medicaid spending for autism care in Indiana, Wisconsin, Maine and Colorado under the microscope, examining 100 monthly bills in each state over a year.
They found potential payment errors in every single one.
According to the audits, Indiana made at least $56 million in improper payouts, Wisconsin $18.5 million, Maine $45.6 million and Colorado a whopping $77.8 million.
Between 2019 and 2025, Medicaid spending on Applied Behavior Analysis (ABA) therapy—the primary treatment protocol for children with autism—has skyrocketed 298% nationwide, according to a report from healthcare analytics company Trilliant Health.
Tatsiana – stock.adobe.comIn 2014, new federal rules required Medicaid to cover autism care. Since then, Autism spectrum disorder (ASD) prevalence in the United States has nearly doubled, from about one in 64 children in 2014 to one in 36 in 2020, with much of the rise attributed to changing diagnostic criteria, increased screening, and greater public awareness.
Payments should not have been made due to reasons like caregivers failed to properly document therapy sessions, lacked the appropriate credentials to provide treatment or patients had not been properly diagnosed with autism.
In addition, in each case the audits flagged separate “potentially improper payments” in each state, which was a much higher number: up to $77 million in Indiana, $22 million in Maine, $94 million in Wisconsin and $207 million in Colorado.
These payments were flagged as carers billing for potential non-therapy time and during recreational activities and not keeping proper notes of the care.
“There’s a big myth that needs to be busted, is the idea that states and the federal government equally share the goal of reducing improper spending,” Chris Medrano, an analyst at the free-market health care research group Paragon Health, told The Post.
He also claimed “a lot” of states use “funding gimmicks” to redirect boatloads of Medicaid money into their general funds, suggesting they may be incentivized to keep the gravy train flowing and turn a blind eye to overbilling.
Although no companies have been prosecuted for fraud related to the HHS audits at this time, the federal government has requested the return of millions of dollars in improper payments from each of the states.
More children are being diagnosed with autism in the US, largely due to increased screening, greater public awareness and a widening of the definition on what counts as autism. Key revisions in 2013 merged previously separate diagnoses into a single Autism Spectrum Disorder (ASD) umbrella.
Feds found “improper or potentially improper” payments in 100 percent of Medicaid-funded autism services sampled across four states in recently published findings—totaling up to $198 million in potentially fraudulent payouts.
Diagnosis rates have gone from 1 in 150 children in 2000 to 1 in 31 children in 2022, according to the CDC.
Some autism researchers, however, have criticized the supposed “epidemic” in autism by suggesting that the new broad criteria has contributed to overdiagnosis.
In 2014, new federal rules required Medicaid to cover autism care. Since then, Medicaid spending on Applied Behavior Analysis (ABA) therapy — the primary treatment protocol for children with autism — has skyrocketed 298% nationwide from seven million hours of therapy administered to 25 million a year in 2024, according to a report from healthcare analytics company Trilliant Health.
Centria Healthcare was the largest Medicaid funded autism care center in the nation, with operations in 12 states as rates of autism diagnoses have exploded since 2014.
As our graph charts, In Indiana, ABA spending rose from $21 million in 2017 to $611 million in 2023 and is projected to reach $825 million by 2029.
North Carolina ABA spending grew from $122 million in 2022 to $329 million by 2024. It is projected to reach an eye-popping $639 million this year.
ABA spending in Nebraska surged from $4.6 million in 2020 to over $83 million in 2024. One provider, Above and Beyond ABA, billed for $29 million alone, according to a state report (it is not suggested they were part of the overbilling).
Colorado ABA payments were $60 million in 2019 and, and $164 million by 2023.
Brown University researcher Daniel Arnold told The Post: “The increases you’re seeing in some states are astronomical […] When private equity comes in usually the price increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
However, none has been more eyepopping than Minnesota which received just over $1 million in Medicaid reimbursements for autism care in 2017, but by 2024 that number had skyrocketed to $343 million, according to the Minnesota Department of Human Resources.
As part of numerous federal prosecutions centered around the Somali community in Minneapolis, in September Asha Farhan Hassan and Abdinajib Hassan Yussuf both pleaded guilty to an autism fraud scheme in Minnesota. Hassan owned Smart Therapy Center and was found to have hired unqualified staff, paid kickbacks of $300–$1,500 per month to parents to recruit children — some not diagnosed with autism — billed for services not provided or inflated hours, and submitted false documentation between 2019 and 2024, according to the Department of Justice.
With all the money sloshing around, private equity has taken note of the seemingly recession-proof profitability potential of Medicaid-funded autism centers.
President Trump announced during last week’s State of the Union address that VP Vance would be heading up the administration’s “war on fraud.”
Quality Learning Center in Minnesota became an emblem of the Minnesota fraud, after allegations it was collecting funds but providing no services. It has since been closed.
In the last decade, private equity firms have acquired over 500 autism centers in the US, according to a January 2026 Brown University study.
Among them, Michigan-based Centria Healthcare LLC, a business which has distributed over half a billion in Medicaid reimbursements. It was acquired by private equity firm Thomas H. Lee Partners in 2019.
Indiana-based Hopebridge LLC, backed by PE firm Arsenal Capital Partners, has also taken in at least $140 million, according to the data.
“The increases you’re seeing in some states are astronomical,” Daniel Arnold, a health policy researcher at Brown University, told The Post.
“When private equity comes in, usually the price [of care] increases, the intensity of services increase as well. In the ABA space this would mean more hours at a higher price.”
Medicaid fraud has been a hot topic since it was revealed last fall that Somali scammers in Minnesota had bilked the state out of an estimated $9 billion in similar schemes.
“It’s not obvious to me that, say, 40 hours a week of ABA is better than 20. It gets to a point where you are crowding out other services kids are doing —like speech therapy, occupational therapy or play activities,” he added.
For those who are proven to have inflated bills, there are consequences.
Two executives at South Carolina Early Autism Project, Angela Breitweiser Keith and Ann Davis Eldridge, were sentenced to a year in prison in 2019 and paid $8.8 million in a settlement for using autism services to defraud Medicaid.
The Department of Justice said the execs had instructed employees to bill for time waiting in driveways and sitting in restaurants; pressured employees to submit exaggerated session timesheets; forged patient signatures and incentivized fraud by establishing high billing goals with rewards like gift cards and company-paid vacations for those who met quotas.
During last week’s State of the Union address, President Trump announced he was appointing Vice President JD Vance to lead a “war on fraud” task force.
“The gold standard solution would be to have some sort of set funding because right now Medicaid is an open-ended reimbursement,” said Medrano. “Have the state internalize the cost of Medicaid so they’re incentivized to save money.”
Sylvia Xu of The Epoch Times teases more conclusions out of the HHS-OIG audit of Colorado's state run Medicaid Applied Behavior Analysis for Children Diagnosed With Autism program:
100 Percent of Audited Medicaid Claims for Autism Care in Colorado Were Improper or Flawed: Report
Colorado Medicaid spending on Applied Behavior Analysis rose 280 percent in five years and suffers from a lack of oversight, according to the Inspector General.
By Sylvia Xu - March 5, 2026Colorado’s Medicaid program made an estimated $77.8 million in improper payments and another $207.4 million in potentially improper payments for autism therapy, according to a February report from the Inspector General for the Department of Health and Human Services.
Auditors investigated $289.5 million in Medicaid payments from 2022 to 2023 that paid for more than 1 million claims for Applied Behavior Analysis—a therapy used to treat autism and developmental disabilities.
Each of the 100 claims reviewed contained at least one improper or potentially improper payment, suggesting a 100 percent failure rate.
Improper payments are not necessarily fraudulent. Payments are considered improper when the claim does not meet federal or state requirements. Payments are potentially improper when the submitted claim is so poor or unreliable that auditors cannot verify that the services were provided correctly.
Claim Errors
In 93 of 100 claims examined, the billing providers either did not provide notes verifying that the therapy took place, didn’t provide the required signatures, or billed for more time than the notes indicated.
In 18 cases, the therapy that was supposed to be performed by a specialist—such as a Board Certified Behavior Analyst—was performed by staff without those qualifications.In seven cases, the children receiving therapy lacked a current doctor’s diagnosis or referral on file.
In 88 cases, facilities billed for recreational activities that are not considered medical therapy, such as academic tutoring, day care, or custodial care. In one case, a facility billed for children swimming and playing on water slides.
In 76 cases, facilities billed for a full eight-hour day without subtracting time for naps, meals, or breaks.
Oversight and Safety Concerns
The report concludes that Colorado made these improper payments because it did not provide effective oversight. The state did not regularly review Medicaid payments to catch errors and failed to give clear guidance to therapy centers on how to bill or what counts as therapy.
Additionally, the state didn’t properly check if its prior authorization contractors were following the rules when approving therapy for children.While the audit focused on money, it also uncovered problems that could affect the safety and quality of care.
Some staff members had criminal convictions for weapons offenses, assault, or driving under the influence. In one case, three staff members at a facility providing care to an 11-year-old child with autism had criminal histories.
A non-credentialed technician had a felony weapons offense conviction three months prior to treating children. A registered behavior technician had been convicted of misdemeanor assault and physical harassment, such as a strike, shove, or kick. Another behavior technician had an aggravated misdemeanor weapons conviction.
The state did not require background checks for these workers.
Previous Audits
The report comes as part of a series of seven Inspector General audits examining state Medicaid payments for autism therapy. Four are are complete and three remain in progress.
In previous audits, the agency estimated more than $120 million in improper payments and nearly $200 million in potential improper payments for Indiana, Wisconsin, and Maine.
The potential fraud, waste, and abuse in Medicaid autism therapy payments in Colorado was the highest among these audits.
The Office of Inspector General recommended that Colorado refund $42.6 million—the federal portion of the improper payments—to the federal government.
Also, the agency suggested that the state begin regular reviews of autism facilities to ensure they follow the rules and provide better training and guidance to facilities on documenting and billing for therapy.
The state of Colorado agreed to improve its guidance and conduct more regular reviews in the future, according to a statement. But it disagreed with the recommendation to refund the money, arguing that the audit derived its findings from a limited sample and didn’t have enough detail on the errors.
Further, Colorado argued that its Medicaid program does not require certification of behavior technicians before making payments, so the refund calculation based on this statute should be rescinded.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













